The chronic fatigue syndrome: clinical-pathophysiological, diagnostic and differential-diagnostic aspects (the literature review and data of own observations). Part 2
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 3
Abstract
The chronic fatigue syndrome (CFS) is a pathological condition, the incidence of which is constantly increasing worldwide, but reliable therapeutic and prophylactic rehab programs have not been developed yet. The paper elucidates the literature data from domestic and foreign sources concerning current methods of prevention, treatment and rehabilitation of CFS patients, as well as attempts to outline possible perspectives in this direction. It is stated that the treatment and rehabilitation of CFS patients should be based on the use of nonmedicated complexes (minimizing risk factors, controlled physical activity, cognitive behavioral therapy, wellness nutrition), and medications (analgesics, antidepressants, activators of metabolism, immunoregulators and alternative medicine). The general treatment principles of patients with CFS according to the international practice have been presented. The main stage of treatment lasts for 12 weeks with the use of multicomponent pharmacologic agents of multidirectional metabolitotropic, immune-corrective action as the basic factors against the background of the abovementioned nondrug and drug approaches. Further stages of rehabilitation are planned in a personalized way, with account of risk factors, social support measures, training and motivation of patients to actively participate in the treatment process. Further stages of rehabilitation can take months and years. The complete recovery is observed not very often, but the longterm remissions are frequent, and CFS recurrence depends on the properly designed treatment programs and the degree of their implementation by the patients. The ways to improve the above methods for over the past 10 years have been shown, and possible prospects in the aspect of rehabilitation of such patients have been outlined. The anticipated changes can be predicted for the treatment paradigm of this disorder from symptomatic therapy to the pathogenetic approach. The syndrome of chronic fatigue is a complex pathological state that is difficult to be treated, and the existing treatment and prophylactic methods require further improvement.
Authors and Affiliations
O. I. Voloshyn, B. P. Seniuk, L. O. Voloshyna, V. P. Prysyazhnyuk
Keywords
Related Articles
- EP ID EP668868
- DOI 10.30978/UTJ2019-3-64
- Views 112
- Downloads 0
The peculiarities of antioxidant protection and its correction at the comorbid course of type 2 diabetes mellitus and gastroesophageal reflux disease
Objective — to study the Actovegin effects on the peculiarities of clinical course and state of antioxidant protection (AOP) of the esophageal mucosa in patients with type 2 diabetes mellitus (DM 2) with concomitant gast...
Algorithm of treatment of patients with pulmonary sarcoidosis
Objective — to develop the algorithm of treatment of patients with pulmonary sarcoidosis, based on the data regarding the rate of contraindications, adverse reactions and resistance to glucocorticosteroids (GCS) and the...
Macrophage migration inhibitory factor and acute myocardial infarction
Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine involved in the development of many acute and chronic inflammatory diseases, including cardiovascular diseases. A link between MIF a...
Investigation of a new indicator of autoimmune accumulation in the genesis of type I diabetes mellitus
Objective — the search for the new marker of autoimmune accumulation in the genesis of type I diabetes mellitus (DM-1). Materials and methods. With the use of immune enzymatic assay, investigations have been performed of...
Influence of hypothyroidism on the level of 8-hydroxy-2’-deoxyguanosine as a biomarker of oxidative damage in comorbid conditions
Objective — to evaluate the hypothyroidism effects on the level of 8-hydroxy-2’-deoxyguanosine (8-OHdG) as a biomarker of oxidative damage in the comorbid course of hypertension (H), type 2 diabetes mellitus (DM2T) and s...